CRGX
Income statement / Annual
Last year (2024), CARGO Therapeutics, Inc. Common Stock's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, CARGO Therapeutics, Inc. Common Stock's net income was -$167.50 M.
See CARGO Therapeutics, Inc. Common Stock,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$7.07 M
|
$3.69 M
|
$1.44 M
|
$147.00 K
|
| Gross Profit |
-$7.07 M
|
-$3.69 M
|
-$1.44 M
|
-$147.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$143.40 M
|
$75.79 M
|
$29.37 M
|
$4.46 M
|
| General & Administrative Expenses |
$43.97 M
|
$20.92 M
|
$5.40 M
|
$1.52 M
|
| Selling & Marketing Expenses |
$0.00
|
-$3.69 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$43.97 M
|
$17.23 M
|
$5.40 M
|
$1.52 M
|
| Other Expenses |
-$7.07 M
|
$0.00
|
-$1.44 M
|
-$147.00 K
|
| Operating Expenses |
$180.30 M
|
$93.02 M
|
$33.33 M
|
$5.83 M
|
| Cost And Expenses |
$187.37 M
|
$96.71 M
|
$34.77 M
|
$5.98 M
|
| Interest Income |
$20.06 M
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$1.60 M
|
$4.94 M
|
$0.00
|
| Depreciation & Amortization |
$7.07 M
|
$3.69 M
|
$1.44 M
|
$147.00 K
|
| EBITDA |
-$160.43 M |
-$93.02 M |
-$34.57 M |
-$5.70 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$19.87 M
|
-$1.44 M
|
-$6.18 M
|
$127.00 K
|
| Income Before Tax |
-$167.50 M
|
-$98.15 M
|
-$40.95 M
|
-$5.85 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$167.50 M
|
-$98.15 M
|
-$40.95 M
|
-$5.85 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
| EPS |
-3.72 |
-2.38 |
-2.13 |
-0.3 |
| EPS Diluted |
-3.72 |
-2.38 |
-2.13 |
-0.3 |
| Weighted Average Shares Out |
$44.97 M
|
$41.21 M
|
$19.23 M
|
$19.47 M
|
| Weighted Average Shares Out Diluted |
$44.97 M
|
$41.21 M
|
$19.23 M
|
$19.47 M
|
| Link |
|
|
|
|
